Rometsch Caroline, Martin Alexandra, Cosci Fiammetta
Department of Experimental and Clinical Medicine, University of Florence, Italy.
School of Human and Social Sciences, University of Wuppertal, Wuppertal, Germany.
Clin Psychol Psychother. 2025 Mar-Apr;32(2):e70075. doi: 10.1002/cpp.70075.
Functional disorders (FDs) benefit from psychotherapy. However, the determinants predicting their efficacy remain largely unexplored.
A systematic literature review was conducted. PubMed, Web of Science, Embase, Cochrane collaboration and grey literature were screened from inception to November 2024. Randomized controlled trials on predictors of success of psychotherapy for FDs (e.g., somatoform disorders, irritable bowel syndrome [IBS], chronic fatigue syndrome/myalgic encephalomyelitis [CFS/ME], fibromyalgia [FM]) in adults (i.e., ≥ 18 years of age) were included. The review yielded 24 eligible studies and included 3382 participants. A standardized quality assessment via ROB-2 Tool was performed. PRISMA guidelines were followed.
Most studies applied CBT-based interventions (n = 19), mainly face-to-face, with some internet-based (n = 5), while fewer used emotional-based (n = 4), mindfulness-based (n = 3), psychodynamic (n = 1) or operant behavioural therapy (n = 1). The primary factors identified as predictive of treatment success in FM and somatization were the intensity of experienced pain. Moreover, the presence of mental disorders, i.e., depression and anxiety disorders, emerged as predictors for a range of disorders including FM, IBS, somatization disorder, hypochondriasis, medically unexplained symptoms and dissociative seizures. Symptom severity was recognized as a predictor across various FDs with findings indicated that severe severity could predict treatment outcomes.
The body of research concerning predictors of treatment success in the context of FDs can help clinicians identifying appropriate psychotherapy trajectories.
Not applicable. PROSPERO no. CRD42022379791; OSF (https://osf.io/8q7z9).
功能性疾病(FDs)可从心理治疗中获益。然而,预测其疗效的决定因素在很大程度上仍未得到探索。
进行了一项系统的文献综述。从创刊至2024年11月,对PubMed、科学网、Embase、Cochrane协作网和灰色文献进行了筛选。纳入了关于成人(即≥18岁)功能性疾病(如躯体形式障碍、肠易激综合征[IBS]、慢性疲劳综合征/肌痛性脑脊髓炎[CFS/ME]、纤维肌痛[FM])心理治疗成功预测因素的随机对照试验。该综述产生了24项符合条件的研究,包括3382名参与者。通过ROB-2工具进行了标准化的质量评估。遵循PRISMA指南。
大多数研究采用基于认知行为疗法(CBT)的干预措施(n = 19),主要是面对面的,有一些基于互联网的(n = 5),而较少使用基于情绪的(n = 4)、基于正念的(n = 3)、心理动力学的(n = 1)或操作性行为疗法(n = 1)。被确定为预测纤维肌痛和躯体化治疗成功的主要因素是经历的疼痛强度。此外,精神障碍的存在,即抑郁症和焦虑症,成为包括纤维肌痛、肠易激综合征、躯体化障碍、疑病症、医学上无法解释的症状和解离性癫痫等一系列疾病的预测因素。症状严重程度被认为是各种功能性疾病的预测因素,研究结果表明严重程度可预测治疗结果。
关于功能性疾病治疗成功预测因素的研究主体可以帮助临床医生确定合适的心理治疗轨迹。
不适用。PROSPERO编号:CRD42022379791;OSF(https://osf.io/8q7z9)。